IFP Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
AC
SCM
VPM
VCM
IFP Advisors's IRWD Position: Q1 2026 in Review
IFP Advisors held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 4,033 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2974.
IFP Advisors first reported a position in IRWD in Q2 2017 and has held it in 18 quarters since. The position peaked at $38K in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- IFP Advisors held 4,033 shares of Ironwood Pharmaceuticals worth $14.2K as of Q1 2026.
- IFP Advisors left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
- Ironwood Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #2974 holding.
- IFP Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2017 and has held it in 18 quarters since.
- IFP Advisors's Ironwood Pharmaceuticals position peaked at $38K in Q4 2022.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.